Excessive blood vessel growth in the retina at the back of the eye is a primary driver of blindness in older individuals. The ...

A new mRNA vaccine developed in Japan has been shown to suppress abnormal blood vessel growth in the retina of mice, offering ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the ...

An mRNA vaccine suppressed abnormal blood vessel growth or neovascularization in the retina of AMD mouse models.

A new mRNA vaccine developed in Japan has been shown to suppress abnormal blood vessel growth in the retina of mice, offering hope to millions of patients with age-related vision loss.

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...

The protein-based vaccine now covers the LP.8.1 variant and can be given to adolescents aged 12 years or older who previously received mRNA vaccines.

Scientists in Japan have developed a new mRNA vaccine that could one day make it easier and more comfortable to treat a ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups ...

"Moreover, administered by injection as a free drug ... Peer's lab for other RNA molecules (such as siRNA, mRNA, circRNA).